Perrigo (PRGO +2.9%) will acquire three Eastern European OTC skincare and hair loss treatment brands including Emolium, Iwostin and Loxon, from Sanofi, for an undisclosed consideration.
Trailing twelve months net sales ending June 30, of the acquired products were ~€21M (~$23)
The transaction is expected to close in the next quarter
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.